Mastisan

to the catalogue

Oily homogeneous suspension for intracisternal administration for mastitis in cattle

Highly effective due to a synergetic effect of the components
Broad-spectrum activity

Composition

Pharmacological properties

Indications

Dosage and method of administration

Restrictions

1 ml Mastisan

streptomycin 28 mg

benzylpenicillin 14 mg

sulfadimizine 70 mg

Please note: The information given on this page is for an informative purpose only. Product characteristics, packaging, label design and overall appearance may vary in different regions. Contact our representatives for more information.

Pharmacological properties

Mastisan has a broad-spectrum antibacterial action against gram-positive and gram-negative microorganisms (Staphylococcus spp., Streptococcus spp., Proteus spp, Escherichia coli, Salmonella spp., etc.)

Indications

Mastisan is prescribed to treat mastitis in lactating cows.

Dosage and method of administration

Before administering the drug, the milk is striped out from the affected udder quarters and disposed; the nipple is to be disinfected.
Heat the contents of the bottle up to 36-39 °C before use, and shake thoroughly to obtain a homogeneous suspension. 5-20 ml of the drug is taken from the bottle with a sterile syringe, the syringe cannula is tightly
pressed against the opening of the nipple canal and injected carefully into the udder cistern by pressing the syringe plunger. After the injection, the nipple of the affected udder quarter is gently massaged from the bottom up.
Depending on the inflammatory process severity, the drug is administered at a dose of 5-20 ml with a 24-hour interval for 5-8 days, in case of purulent and purulent-catarrhal mastitis for up to 10 days.

Restrictions

Contraindications and special instructions:
Avoid using Mastisan simultaneously with other antimastitis drugs requiring intracisternal administration.

Withdrawal period:
milk: 3 days